GL1X · GenesisL1 explorer

MolNFT v1 · #32687 · protein

Dual binding mode of a novel series of dhodh inhibitors

2BXV · Dihydroorotate dehydrogenase: “Dual binding mode of a novel series of dhodh inhibitors”. X-ray diffraction, 4 ligands (FMN, ORO, 3FT), 5 pockets (best druggability 0.83). MolNFT v1 #32687 on GenesisL1: 3D structure, binding sites…

PDB
2BXV
Type
protein
Length
360 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase
EC
1.3.3.1
UniProt
Q02127
Ligands
FMN, ORO, 3FT, SO4
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (EC 1.3.3.1)protein36045% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • 3FT · 2-({[3-fluoro-3'-(trifluoromethoxy)biphenyl-4-yl]amino}carbonyl)cyclopent-1-ene-1-carboxylic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14560.830.9063FMN, ORO, 3FT
21620.490.7727empty
3900.420.7919empty
4840.420.7919empty
5730.320.7515empty

Compared structures

  • 2BXV · Dual binding mode of a novel series of DHODH inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q02127 · AlphaFold monomer V2.0 prediction for dihydroorotate dehydrogenase (quinone)… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.